755 related articles for article (PubMed ID: 26470915)
1. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hepatic drug-metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein.
Ghose R; White D; Guo T; Vallejo J; Karpen SJ
Drug Metab Dispos; 2008 Jan; 36(1):95-101. PubMed ID: 17932222
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells.
Mori K; Fujisawa T; Kusagaya H; Yamanaka K; Hashimoto D; Enomoto N; Inui N; Nakamura Y; Maekawa M; Suda T
PLoS One; 2015; 10(9):e0139491. PubMed ID: 26418032
[TBL] [Abstract][Full Text] [Related]
4. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
5. Toll/IL-1 domain-containing adaptor inducing IFN-β (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation.
Hwang EH; Kim TH; Oh SM; Lee KB; Yang SJ; Park JH
Cytokine; 2016 Jan; 77():127-34. PubMed ID: 26579632
[TBL] [Abstract][Full Text] [Related]
6. Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes.
Ghose R; Guo T; Vallejo JG; Gandhi A
Drug Metab Dispos; 2011 May; 39(5):874-81. PubMed ID: 21303924
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
8. Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.
Hu W; Jain A; Gao Y; Dozmorov IM; Mandraju R; Wakeland EK; Pasare C
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13994-9. PubMed ID: 26508631
[TBL] [Abstract][Full Text] [Related]
9. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
10. Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.
Zhang L; Xiang W; Wang G; Yan Z; Zhu Z; Guo Z; Sengupta R; Chen AF; Loughran PA; Lu B; Wang Q; Billiar TR
J Biol Chem; 2016 Jul; 291(29):15093-107. PubMed ID: 27226571
[TBL] [Abstract][Full Text] [Related]
11. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.
Ahmed S; Maratha A; Butt AQ; Shevlin E; Miggin SM
J Immunol; 2013 Mar; 190(5):2217-28. PubMed ID: 23365087
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
14. Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.
Mallick P; Basu S; Moorthy B; Ghose R
Toxicol In Vitro; 2017 Jun; 41():75-82. PubMed ID: 28242239
[TBL] [Abstract][Full Text] [Related]
15. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
[TBL] [Abstract][Full Text] [Related]
16. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
17. TRIM8 Negatively Regulates TLR3/4-Mediated Innate Immune Response by Blocking TRIF-TBK1 Interaction.
Ye W; Hu MM; Lei CQ; Zhou Q; Lin H; Sun MS; Shu HB
J Immunol; 2017 Sep; 199(5):1856-1864. PubMed ID: 28747347
[TBL] [Abstract][Full Text] [Related]
18. MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll/IL-1 receptor-domain-containing adapter-inducing IFN-β (TRIF) recruitment to Toll-like receptor 3.
Kato K; Lillehoj EP; Kim KC
Am J Respir Cell Mol Biol; 2014 Sep; 51(3):446-54. PubMed ID: 24693944
[TBL] [Abstract][Full Text] [Related]
19. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
20. Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice.
Imamura M; Tsutsui H; Yasuda K; Uchiyama R; Yumikura-Futatsugi S; Mitani K; Hayashi S; Akira S; Taniguchi S; Van Rooijen N; Tschopp J; Yamamoto T; Fujimoto J; Nakanishi K
J Hepatol; 2009 Aug; 51(2):333-41. PubMed ID: 19501931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
